Showing results (71-80 of 94) with videos related to
Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|October 16, 2004
Discovery of highly potent, selective, orally bioavailable, metabotropic glutamate subtype 5 (mGlu5) receptor antagonists devoid of cytochrome P450 1A2 inhibitory activityNicholas D Smith, Steve F Poon, Dehua Huang, et al.International Journal of Radiation Oncology, Biology, Physics|April 29, 1999
Recurrent nasopharyngeal carcinoma: the puzzles of long latencyA W Lee, W Foo, S C Law, et al.International Journal of Cancer|March 30, 1999
Staging of nasopharyngeal carcinoma: from Ho's to the new UICC systemA W Lee, W Foo, S C Law, et al.Bioorganic & Medicinal Chemistry Letters|September 27, 2005
3-[Substituted]-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitriles: identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonistsLida R Tehrani, Nicholas D Smith, Dehua Huang, et al.International Journal of Cancer|August 1, 1980
Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynxD P Huang, J H Ho, Y F Poon, et al.Ecotoxicology (London, England)|March 20, 2002
Risk to breeding success of Ardeids by contaminants in Hong Kong: evidence from trace metals in feathersD W Connell, B S F Wong, P K S Lam, et al.International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
Total biological effect on late reactive tissues following reirradiation for recurrent nasopharyngeal carcinomaA W Lee, W Foo, S C Law, et al.International Journal of Radiation Oncology, Biology, Physics|December 1, 1994
T1 nasopharyngeal carcinoma: the effect of waiting time on tumor controlA W Lee, D K Chan, J F Fowler, et al.Journal of Medicinal Chemistry|October 20, 2009
Discovery and optimization of substituted 1-(1-phenyl-1H-pyrazol-3-yl)methanamines as potent and efficacious type II calcimimeticsSteve F Poon, David J St Jean, Paul E Harrington, et al.Cancer|April 15, 1988
Clinical diagnosis of late temporal lobe necrosis following radiation therapy for nasopharyngeal carcinomaA W Lee, S H Ng, J H Ho, et al.Pageof 10